Headache is a common symptom of ischemic and hemorrhagic stroke (1, 2). In this issue of Cephalalgia, two studies of headache and cerebrovascular disease are reported (3, 4). Arboix et al. (3) present the results of a prospective study of the frequency and clinical characteristics of headache in stroke. The authors found that: (a) all patients with subarachnoid hemorrhage develop headache; (b) headache occurs more commonly with hemorrhagic than with ischemic stroke; (c) patients with ischemic stroke in the vertebrobasilar territory are more likely to complain of headache than patients with carotid territory stroke; and (d) the clinical characteristics of stroke-related headaches are variable and do not predict the mechanism or the location of the cerebral event. Similar conclusions have been reached in several other series (1, 2). In our Henry Ford Hospital Stroke Data Bank, the frequency of headache with ischemic stroke was 30%; vertebrobasilar territory strokes were more likely to cause headache than carotid territory strokes. It is intriguing that headache is a more consistent feature of vertebrobasilar than carotid territory strokes. Possibly, the former activates the trigemino-vascular system and thus causes headache more frequently. Arboix et al.
Evaluating the IHS criteria RICHARD B LIPTON, WALTER F STEWART
The International Headache Society criteria represent a critical advance in the development of a diagnostic system for headache (1) . This system must be evaluated in terms of its reliability and validity (2) . The paper by Granella et al. in this issue of Cephalalgia focuses on one of the essential aspects of this evaluation process, diagnostic reliability. If a diagnostic system is reliable, then patients will reproducibly receive the same diagnosis (or diagnoses) on successive evaluations. Though diagnostic reliability is required for effective communication among clinicians and for scientific progress, it is difficult to study and even more difficult to achieve.
Diagnostic reliability is essential to understanding the efficacy of new treatments in clinical trials, to discovering biologic markers, and to epidemiologic research (3) (4) (5) . For example, in a migraine clinical trial, unreliability may lead to the randomization of non-migraineurs; if a treatment is effective for migraine but not for the headaches misdiagnosed as migraine, the efficacy of treatment will be underestimated or completely missed. Unreliability will also usually result in underestimates of measured associations between biological markers, and migraine (5) . Finally, evaluating the diagnostic reliability of the "gold standard" is essential to understanding the sensitivity and specificity of screening tools such as diagnostic questionnaires and telephone interviews. If the gold standard diagnosis is unreliable, the sensitivity and specificity of the screening test will be underestimated.
Thus, the study of diagnostic reliability is of critical importance for advancing our understanding of headache disorders. In their discussion, the authors utilize an approach to partitioning unreliability developed by Shrout and coworkers for psychiatric disease and then applied to headache (2, 6) . This approach distinguishes criterion variance, information variance and interpretation variance as major categories of unreliability. The authors took steps to limit each of these sources of unreliability. They limited criterion variance by using IHS criteria. They minimized information variance by using semistructured interviews-so that the same questions are asked-and by videotaping interviews-so that the patient responses are uniform. They limited interpretation variance by having study clinicians discuss diagnostic rules. Their meticulous attention to methods helps account for their excellent results.
The paper points out that even using the IHS system criterion variance may be an important source of unreliability. Though the IHS makes clear which features are required and which features exclude diagnosis, in practice the clinician must decide how to ask about particular symptoms and whether or not they are present. For example, the definition of unilateral pain is not completely clear. Pain may be exclusively unilateral. It may begin on one side and subsequently become bilateral. It may be bilateral from onset with a unilateral preponderance or unilateral exacerbations. If clinicians differ in their definitions of unilateral pain, diagnostic unreliability will result.
Based on a review of diagnostic disagreements, the authors make a number of specific suggestions, for decreasing criterion variance by making the IHS criteria more explicit. They recommend modifying the criteria for unilateral pain, throbbing pain, and aggravation by routine physical activity. Though their recommendations are sensible, we advise caution before these proposals are accepted as final. First, their study was conducted in a sample from two specialty clinics. Because these patients are likely to have severe headaches, the results may not be generalizable to primary care settings. Second, because videotaped interviews were reviewed, variation in patient responses was eliminated, making it impossible to assess information variance. Third, before criteria are changed, it should be empirically demonstrated that the proposed revisions actually improve reliability. Finally, a useful classification system must be valid as well as reliable (7) . The effects of altering the criteria on various indices of validity should be studied before changes are introduced.
Despite the cautionary notes, Granella et al. have taken a vital step in the further development of a scientific diagnostic system for headache disorders. We hope that others will follow their lead by assessing the reliability, validity, completeness and generalizability of the IHS criteria in primary care settings and in population-based samples, as well as in specialty clinics.
Quantitative EEG analysis AHMAD BEYDOUN
The utility of quantitative EEG analysis in the evaluation of patients with migraine remains controversial. In this issue, Genco et al. report that adults with migraine have a significant increase in relative delta power, whereas children have a significant increase in relative theta power compared to age-matched controls. Other investigators have described similar findings, other abnormalities or no abnormality in this condition. This variability stems from a lack of standardization with analysis of absolute power, relative power, asymmetry, peak frequency analysis, etc. When one adds the different reference locations, varied states of alertness, epoch duration and total duration analyzed, it becomes clear why a lack of standardized analysis could yield different results by different investigators.
In analysis of quantitative EEG, the most critical variables are the quality of the data, selection of artifact-free epochs and using optimum statistical methods. Use of a t-test assumes that the data obtained are normally distributed, which is frequently not the case with absolute and relative power. Thus, unless a transformation is performed to normalize the data, a level of 2. or 3 standard deviations need not reflect statistical significance, With use of a 2-standard deviation to determine significance, one of 20 observations will be statistically significant by chance alone. With the amount of data generated by quantitative analysis, some of the values will fulfill that degree of significance. To prevent these types of statistical significances that need not reflect clinical significance, it is important to use the quantitative EEG analysis to test a specific hypothesis prior to data collection and not to embark on a "fishing expedition" of statistical significance. This, coupled with more standardized techniques, will allow us to determine the clinical usefulness of quantitative EEG in improving our understanding of the neurophysiological abnormalities present in patients with migraine.
Serotonin, sumatriptan and mononuclear cells RAJIV JOSEPH
Increasing evidence supports the presence of altered serotonin metabolism in migraine; however, the precise mechanisms by which these changes are related to the pathogenesis of migraine remain somewhat speculative. Recent evidence that sumatriptan, a serotonin agonist, helps relieve attacks in many migraineurs further supports a role for serotonin. In this issue of Cephalalgia, Martelletti et al. have studied the binding of fluorescein-labelled serotonin to peripheral blood mononuclear cells and estimated the changes using flow cytometry. In a group of migraine sufferers in whom headache was induced by the administration of sublingual nitrate, the binding of serotonin to mononuclear cells was increased along with an increase in serum levels of serotonin. Similar results would be expected during spontaneous migraine attacks, although this has not been studied in this report. These findings, together with their previously reported findings, may suggest enhanced affinity or upregulation of receptor numbers on mononuclear cells during migraine. The binding of serotonin to mononuclear cells was not reversed by sumatriptan, but the headache was. Although, these results suggest that the beneficial effect of sumatriptan does not involve the direct binding of serotonin to mononuclear cells, direct mechanisms need investigation.
